Champions Oncology Inc

Entity type image
Type: Company
Name: Champions Oncology Inc
First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Unorthodox treatment helps 9-year-old beat cancer

When multiple rounds of chemotherapy and radiation failed to stop the cancerous tumors growing in 9-year-old Michael Feeney’s chest and lungs, his parents sought out a novel treatment, The Record reported.The Ridgewood, N.J., couple paid an independent ... [Published FOXNews.com - Apr 22 2013]
Entities: Cancer, Tumor, Drugs
First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Form 8-K CHAMPIONS ONCOLOGY, INC. For: Apr 22

StreetInsider.com - Form 8-K CHAMPIONS ONCOLOGY, INC. For: Apr 22 ... [Published Street Insider - Apr 22 2013]
First reported Apr 16 2013 - Updated Apr 16 2013 - 1 reports

Lab Mice Help Ridgewood Boy Beat Rare Bone Cancer

Nine-year-old Michael Feeney of Ridgewood has been fighting Ewing’s sarcoma, a rare bone cancer, since he was 6.After standard treatments to reduce the cancerous tumors were repeatedly unsuccessful, Michael’s parents took a chance on a long shot- lab ... [Published NewJerseyNewsroom.com - Apr 16 2013]
First reported Apr 14 2013 - Updated Apr 14 2013 - 1 reports

Mice help Ridgewood boy fight cancer

The laboratory, Hackensack-based Champions Oncology, found a three-drug cocktail that destroyed the cancer cells in some mice and also worked on 9-year-old Michael Feeney.Using mice gives Champions the ability to test multiple drugs on any patient's tumor ... [Published Hunterdon County Democrat - Apr 14 2013]
First reported Mar 14 2013 - Updated Mar 14 2013 - 1 reports

8-K - CHAMPIONS ONCOLOGY, INC. (0000771856) (Filer)

Filed: 2013-03-14 AccNo: 0001144204-13-014923 Size: 187 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits ... [Published SEC Filings - Mar 14 2013]
First reported Feb 05 2013 - Updated Feb 05 2013 - 1 reports

Champions Oncology gets $9.3mm in private placement

Home » Blogs » [Champions Oncology] gets $9.3mm in private placementPersonalized cancer treatment developer [Champions Oncology Inc.] has grossed $9.3mm through the private placement of 18.6mm common shares at $0.50 (a 56% premium). Investors--which included ... [Published BioPortfolio - Feb 05 2013]
First reported Jan 31 2013 - Updated Jan 31 2013 - 1 reports

Champions Oncology Raises $9.3 Million in Private Placement

Champions Oncology of Hackensack, N.J., earlier this week announced it had raised $9.3 million at a price of $0.50 per share in a private placement to existing and new investors. That group includes Battery Ventures IX, L.P., PAR Investment Partners ... [Published PE Hub News - Jan 31 2013]

Quotes

Mother Jill Feeney said, according to NorthJersey.com, "I’ve been saying we’re the luckiest unlucky people I know.”"
"The great thing about this is Michael didn't have to be a guinea pig with all the drugs" Jill Feeney, Michael's mother, said
...These are then injected percutaneously into the necrotic or fracture region, avoiding the need for more invasive surgical procedures. "We think we are the only company pursuing osteoblast cells for therapeutic purposes in oesteonecrosis, whereas potential competitors are using differentiated bone stem cells,” CEO Enrico Bastianelli told our Pink Sheet DAILY colleagues. Osteonecrosis is a progressive degenerative disease of bone, most commonly seen in the hips of relatively young patients age 30 to 50 years. – John Davis"
...No commissions were paid in connection with the private placement. Joel Ackerman, Champions Oncology CEO, stated, "We are pleased to have the continued support of our existing shareholders and to announce the addition of a new high quality investor. These proceeds will allow us to move forward with developing our technology and building our team."

More Content

All (22) | News (13) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (8)
sort by: Date | Relevance
Form 8-K CHAMPIONS ONCOLOGY, INC. For: Apr 22 [Published Street Insider - Apr 22 2013]
Unorthodox treatment helps 9-year-old beat cancer [Published FOXNews.com - Apr 22 2013]
An unorthodox but growing treatment in a 9-year... [Published Keene Sentinel - Apr 20 2013]
Lab Mice Help Ridgewood Boy Beat Rare Bone Cancer [Published NewJerseyNewsroom.com - Apr 16 2013]
Mice help Ridgewood boy fight cancer [Published Hunterdon County Democrat - Apr 14 2013]
Unorthodox testson rodents help Ridgewood 9-yea... [Published North Jersey.com - Apr 14 2013]
Champions Oncology to Exhibit and Present 6 Pos... [Published GlobeNewswire: Acquisitions News - Apr 04 2013]
8-K - CHAMPIONS ONCOLOGY, INC. (0000771856) (Fi... [Published SEC Filings - Mar 14 2013]
Champions Oncology Reports Record Results for t... [Published GlobeNewswire: Acquisitions News - Mar 14 2013]
Champions Oncology to Report Third Quarter Fina... [Published GlobeNewswire: Advertising News - Mar 08 2013]
8-K - CHAMPIONS ONCOLOGY, INC. (0000771856) (Fi... [Published SEC Filings - Mar 05 2013]
Champions Oncology Reports Changes to Board of ... [Published GlobeNewswire: Advertising News - Mar 05 2013]
Champions Oncology Reports Successful Outcome F... [Published GlobeNewswire: Advertising News - Feb 11 2013]
Financings of the Fortnight Sees Signs That Poi... [Published The IN VIVO Blog - Feb 08 2013]
Champions Oncology gets $9.3mm in private place... [Published BioPortfolio - Feb 05 2013]
Champions Oncology Raises $9.3 Million in Priva... [Published PE Hub News - Jan 31 2013]
8-K - CHAMPIONS ONCOLOGY, INC. (0000771856) (Fi... [Published SEC Filings - Jan 30 2013]
Champions Oncology Raises $9.3 Million in a Pri... [Published GlobeNewswire: Advertising News - Jan 30 2013]
8-K - CHAMPIONS ONCOLOGY, INC. (0000771856) (Fi... [Published SEC Filings - Jan 07 2013]
Champions Oncology Reports Financial Results fo... [Published PR Newswire: Financial Services - Dec 13 2012]
Champions Oncology Announces Geographic Expansion [Published GlobeNewswire: Advertising News - Dec 13 2012]
8-K - CHAMPIONS ONCOLOGY, INC. (0000771856) (Fi... [Published SEC Filings - Aug 03 2012]
1
In Focus
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Financings of the Fortnight Sees Signs That Poi... [Published The IN VIVO Blog - Feb 08 2013]
Oh, the siren song. The new year arrives, the buzz and handshakes at the JPMorgan conference get everyone hopped up, and a scramble of biotech IPO activity lights up the wires. In 2012 it was Verastem, Adocia, Cempra and Chemocentryx all going through ...
1

Press Releases

sort by: Date | Relevance
Champions Oncology to Exhibit and Present 6 Pos... [Published GlobeNewswire: Acquisitions News - Apr 04 2013]
Champions Oncology Reports Record Results for t... [Published GlobeNewswire: Acquisitions News - Mar 14 2013]
Champions Oncology to Report Third Quarter Fina... [Published GlobeNewswire: Advertising News - Mar 08 2013]
Champions Oncology Reports Changes to Board of ... [Published GlobeNewswire: Advertising News - Mar 05 2013]
Champions Oncology Reports Successful Outcome F... [Published GlobeNewswire: Advertising News - Feb 11 2013]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.